Year in review 2011: Acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer

Respirology

Volumn 17, Issue 3, 2012, Pages 554-562

  Takahashi, Kazuhisa ^a   Eves, Neil D ^b   Piper, Amanda ^c,d   Song, Yuanlin ^e,f,g   Maher, Toby M ^h,i,j  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^f Shanghai Public Health Clinical Centre   (China)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h ROYAL BROMPTON HOSPITAL   (United Kingdom)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

acute respiratory distress syndrome; idiopathic pulmonary fibrosis; mesothelioma; obstructive sleep apnoea; sarcoidosis

Indexed keywords

ASBESTOS; CAPSAICIN; EVEROLIMUS; TOXIC GAS;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COUGHING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DYSPNEA; FIBROSING ALVEOLITIS; FOLLOW UP; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; INTERSTITIAL LUNG DISEASE; ISCHEMIC HEART DISEASE; LUNG CANCER; LUNG EMPHYSEMA; LUNG INFECTION; LUNG NON SMALL CELL CANCER; MESOTHELIOMA; PHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SARCOIDOSIS; SLEEP APNEA SYNDROME; STEM CELL TRANSPLANTATION;

EID: 84859088499     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02127.x     Document Type: Review

References (76)

1. Phua J, Badia JR, Adhikari NK, et al,. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am. J. Respir. Crit. Care Med. 2009; 179: 220-7.
2. Robinson B, Alatas MF, Robertson A, et al,. Natural disasters and the lung. Respirology 2011; 16: 386-95.
3. Caraballo JC, Yshii C, Westphal W, et al,. Ambient particulate matter affects occludin distribution and increases alveolar transepithelial electrical conductance. Respirology 2011; 16: 340-9.
4. Tagami T, Kushimoto S, Tosa R, et al,. Plasma neutrophil elastase correlates with pulmonary vascular permeability: a prospective observational study in patients with pneumonia. Respirology 2011; 16: 953-8.
5. Bastin AJ, Sato H, Davidson SJ, et al,. Biomarkers of lung injury after one-lung ventilation for lung resection. Respirology 2011; 16: 138-45.
6. Dakin J, Jones AT, Hansell DM, et al,. Changes in lung composition and regional perfusion and tissue distribution in patients with ARDS. Respirology 2011; 16: 1265-72.
7. Krasnodembskaya A, Song Y, Fang X, et al,. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229-38.
8. Lee JW, Fang X, Gupta N, et al,. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl Acad. Sci. USA 2009; 106: 16357-62.
9. Mei SH, Haitsma JJ, Dos Santos CC, et al,. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am. J. Respir. Crit. Care Med. 2010; 182: 1047-57.
10. Maher TM,. Pirfenidone in idiopathic pulmonary fibrosis. Drugs Today 2010; 46: 473-82.
11. Malouf MA, Hopkins P, Snell G, et al,. An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis. Respirology 2011; 16: 776-83.
12. Lee JS, Collard HR,. Primum non nocere: safety in clinical trials for IPF. Respirology 2011; 16: 723-4.
13. Wang X, Wu G, Gou L, et al,. A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice. Respirology 2011; 16: 500-7.
14. Maher TM, Wells AU,. Lost in translation; from animal models of pulmonary fibrosis to human disease. Respirology 2009; 14: 915-6.
15. Kozu R, Jenkins S, Senjyu H,. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 1196-202.
16. Eves ND, Koelwyn GJ,. Short of breath, short of benefit: important considerations for the rehabilitation of IPF patients. Respirology 2011; 16: 1163-4.
17. Ryerson CJ, Abbritti M, Ley B, et al,. Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology 2011; 16: 969-75.
18. Zisman DA, Schwarz M, Anstrom KJ, et al,. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N. Engl. J. Med. 2010; 363: 620-8.
19. Maher TM, Wells AU,. Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis? Respirology 2011; 16: 381-3.
20. Swigris JJ, Olson AL, Shlobin OA, et al,. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 439-45.
21. Boutou AK, Pitsiou GG, Trigonis I, et al,. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology 2011; 16: 451-8.
22. Nathan SD, Weir N, Shlobin OA, et al,. The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 481-6.
23. Judson MA,. Sarcoidosis: lost in translation. Respirology 2011; 16: 384-5.
24. Okumus G, Musellim B, Cetinkaya E, et al,. Extrapulmonary involvement in patients with sarcoidosis in Turkey. Respirology 2011; 16: 446-50.
25. Umeda Y, Demura Y, Morikawa M, et al,. Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis. Respirology 2011; 16: 713-20.
26. Corte TJ, Wells AU, Nicholson AG, et al,. Pulmonary hypertension in sarcoidosis: a review. Respirology 2011; 16: 69-77.
27. Peppard PE, Young T, Palta M, et al,. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-21.
28. Chen R, Xiong K-P, Huang J-Y, et al,. Neurocognitive impairment in Chinese patients with obstructive sleep apnoea hypopnoea syndrome. Respirology 2011; 16: 842-8.
29. Quan SF, Chan CS, Dement WC, et al,. The association between obstructive sleep apnea and neurocognitive performanceâthe Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep 2011; 34: 303-14.
30. Gami AS, Howard DE, Olson EJ, et al,. Day-night pattern of sudden death in obstructive sleep apnea. N. Engl. J. Med. 2005; 352: 1206-14.
31. Sasai T, Inoue Y, Matsuo A, et al,. Changes in respiratory disorder parameters during the night in patients with obstructive sleep apnoea. Respirology 2011; 16: 116-23.
32. Epstein LJ, Kristo D, Strollo PJ, et al,. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J. Clin. Sleep Med. 2009; 5: 263-76.
33. Chou K-T, Chang Y-T, Chen Y-M, et al,. The minimum period of polysomnography required to confirm a diagnosis of severe obstructive sleep apnoea. Respirology 2011; 16: 1096-102.
34. Marks GB,. Are reference equations for spirometry an appropriate criterion for diagnosing disease and predicting prognosis? Thorax 2012; 67: 85-7.
35. Garcia-Rio F, Soriano JB, Miravitlles M, et al,. Overdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of life. Chest 2011; 139: 1072-80.
36. Thompson BR, Stanojevic S, Abramson MJ, et al,. The all-age spirometry reference ranges reflect contemporary Australasian spirometry. Respirology 2011; 16: 912-7.
37. Stanojevic S, Wade A, Stocks J,. Reference values for lung function: past, present and future. Eur. Respir. J. 2010; 36: 12-9.
38. Enright P,. The new all-age spirometry reference equations are the best available for Caucasians, regardless of where they live. Respirology 2011; 16: 871-2.
39. Kontakiotis T, Boutou AK, Ioannidis D, et al,. Spirometry values in a Greek population: is there an appropriate reference equation? Respirology 2011; 16: 947-52.
40. Quanjer PH, Tammeling GJ, Cotes JE, et al,. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. Suppl. 1993; 16: 5-40.
41. Hankinson JL, Odencrantz JR, Fedan KB,. Spirometric reference values from a sample of the general U.S. population. Am. J. Respir. Crit. Care Med. 1999; 159: 179-87.
42. Kuster SP, Kuster D, Schindler C, et al,. Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years. Eur. Respir. J. 2008; 31: 860-8.
43. Ip MSM,. Lung function testing in health and disease: issues pertaining to Asiaââ'Pacific populations. Respirology 2011; 16: 190-7.
44. Dashdendev B, Fukushima LK, Woo MS, et al,. Carbon monoxide pollution and lung function in urban compared with rural Mongolian children. Respirology 2011; 16: 653-8.
45. King GG,. Cutting edge technologies in respiratory research: lung function testing. Respirology 2011; 16: 883-90.
46. Kalhoff H, Breidenbach R, Smith H-J, et al,. Impulse oscillometry in preschool children and association with body mass index. Respirology 2011; 16: 174-9.
47. Nowowiejska B, Tomalak W, Radlinski J, et al,. Transient reference values for impulse oscillometry for children aged 3-18 years. Pediatr. Pulmonol. 2008; 43: 1193-7.
48. Qiu Z, Yu L, Xu S, et al,. Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux. Respirology 2011; 16: 645-52.
49. Pavord ID, Chung KF,. Management of chronic cough. Lancet 2008; 371: 1375-84.
50. Chatkin JM, Ansarin K, Silkoff PE, et al,. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am. J. Respir. Crit. Care Med. 1999; 159: 1810-3.
51. Hahn PY, Morgenthaler TY, Lim KG,. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin. Proc. 2007; 82: 1350-5.
52. Pacheco A, Faro V, Cobeta I, et al,. Gastro-oesophageal reflux, eosinophilic airway inflammation and chronic cough. Respirology 2011; 16: 994-9.
53. Crescimanno G, Marrone O, Vianello A,. Efficacy and comfort of volume-guaranteed pressure support in patients with chronic ventilatory failure of neuromuscular origin. Respirology 2011; 16: 672-9.
54. Ramos EM, De Toledo AC, Xavier RF, et al,. Reversibility of impaired nasal mucociliary clearance in smokers following a smoking cessation programme. Respirology 2011; 16: 849-55.
55. Gratziou C,. Respiratory, cardiovascular and other physiological consequences of smoking cessation. Curr. Med. Res. Opin. 2009; 25: 535-45.
56. Scanlon PD, Connett JE, Waller LA, et al,. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med. 2000; 161: 381-90.
57. Kotecha S, Westall GP, Holsworth L, et al,. Long-term outcomes from bronchoscopic lung volume reduction using a bronchial prosthesis. Respirology 2011; 16: 167-73.
58. Parkin DM, Bray FI, Devesa SS,. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 2001; 37 (Suppl 8): S4-66.
59. Lam K-C, Mok TS,. Targeted therapy: an evolving world of lung cancer. Respirology 2011; 16: 13-21.
60. Sriram KB, Larsen JE, Yang IA, et al,. Genomic medicine in non-small cell lung cancer: paving the path to personalized care. Respirology 2011; 16: 257-63.
61. Campbell JD, Spira A, Lenburg ME,. Applying gene expression microarrays to pulmonary disease. Respirology 2011; 16: 407-18.
62. Cullum R, Alder O, Hoodless PA,. The next generation: using new sequencing technologies to analyse gene regulation. Respirology 2011; 16: 210-22.
63. Putra AC, Tanimoto K, Arifin M, et al,. Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer. Respirology 2011; 16: 796-802.
64. Son JW, Kim YJ, Cho HM, et al,. Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer. Respirology 2011; 16: 1203-9.
65. Young RP, Hopkins RJ, Christmas T, et al,. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J. 2009; 34: 380-6.
66. Young RP, Hopkins RJ,. How the genetics of lung cancer may overlap with COPD. Respirology 2011; 16: 1047-55.
67. Cottin V, Nunes H, Brillet PY, et al,. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586-93.
68. Usui K, Tanai C, Tanaka Y, et al,. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011; 16: 326-31.
69. Iwao K, Watanabe T, Fujiwara Y, et al,. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. International journal of cancer Journal international du. Cancer 2001; 91: 433-7.
70. Lv M, Wu M-Z, Zhao Y-J, et al,. Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer. Respirology 2011; 16: 1076-80.
71. Trisolini R, Cancellieri A, Tinelli C, et al,. Performance characteristics and predictors of yield from transbronchial needle aspiration in the diagnosis of peripheral pulmonary lesions. Respirology 2011; 16: 1144-9.
72. Kamiya K, Watanabe M, Kohno M, et al,. KL-6 and CEA levels in epithelial lining fluid microsamples predict response to gefitinib in patients with advanced non-small cell lung cancer. Respirology 2011; 16: 976-82.
73. Meng X, Wang G, Liu P, et al,. ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells. Respirology 2011; 16: 1228-34.
74. Standfield L, Weston AlR, Barraclough H, et al,. Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence. Respirology 2011; 16: 1210-20.
75. van Meerbeeck JP, Damhuis R,. Facts, rumours and speculations about the mesothelioma epidemic. Respirology 2011; 16: 1018-19.
76. Le GV, Takahashi K, PARK E-K, et al,. Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology 2011; 16: 767-75.